Europe dibigatran Market Report to 2021

October 2016 | 102 pages | ID: EE279F7C1A3EN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of dibigatran

Revenue, means the sales value of dibigatran

This report studies sales (consumption) of dibigatran in Europe market, especially in Germany, UK, France, Italy, Spain and Russia, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering

• Pfizer, Inc. (US)
• Bayer Healthcare AG (Germany)
• GlaxoSmithKline Plc. (UK)
• Boehringer Ingelheim (Germany)
• Sanofi S.A. (France)
• Abbott India Limited (India)
• Aspen Holdings (South Africa)
• Bristol-Myers Squibb Company (US)
• Eisai Inc. (US)
• Mitsubishi Tanabe Pharma Corporation (Japan)
• Teva Pharmaceutical Industries Ltd. (Israel)

Market Segment by Regions, this report splits Europe into several key Regions, with sales (consumption), revenue, market share and growth rate of dibigatran in these regions, from 2011 to 2021 (forecast), like

• Germany
• France
• UK
• Italy
• Spain
• Russia

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Type I
• Type II
• Type III

Split by applications, this report focuses on sales, market share and growth rate of dibigatran in each application, can be divided into

• stroke
• deep vein thrombosis
• pulmonary embolism
• systemic embolism

Contents

1 DIBIGATRAN OVERVIEW

1.1 Product Overview and Scope of dibigatran
1.2 Classification of dibigatran
  1.2.1 Type I
  1.2.2 Type II
  1.2.3 Type III
1.3 Applications of dibigatran
  1.3.1 stroke
  1.3.2 deep vein thrombosis
  1.3.3 pulmonary embolism
  1.3.4 systemic embolism
1.4 dibigatran Market by Regions
  1.4.1 Germany Status and Prospect (2011-2021)
  1.4.2 France Status and Prospect (2011-2021)
  1.4.3 UK Status and Prospect (2011-2021)
  1.4.4 Italy Status and Prospect (2011-2021)
  1.4.5 Spain Status and Prospect (2011-2021)
  1.4.6 Russia Status and Prospect (2011-2021)
1.5 Europe Market Size (Value and Volume) of dibigatran (2011-2021)
  1.5.1 Europe dibigatran Sales, Revenue and Price (2011-2021)
  1.5.2 Europe dibigatran Sales and Growth Rate (2011-2021)
  1.5.3 Europe dibigatran Revenue and Growth Rate (2011-2021)

2 EUROPE DIBIGATRAN BY MANUFACTURERS, TYPE AND APPLICATION

2.1 Europe dibigatran Market Competition by Manufacturers
  2.1.1 Europe dibigatran Sales and Market Share of Key Manufacturers (2015 and 2016)
  2.1.2 Europe dibigatran Revenue and Share by Manufacturers (2015 and 2016)
2.2 Europe dibigatran (Volume and Value) by Type
  2.2.1 Europe dibigatran Sales and Market Share by Type (2011-2021)
  2.2.2 Europe dibigatran Revenue and Market Share by Type (2011-2021)
2.3 Europe dibigatran (Volume and Value) by Regions
  2.3.1 Europe dibigatran Sales and Market Share by Regions (2011-2021)
  2.3.2 Europe dibigatran Revenue and Market Share by Regions (2011-2021)
2.4 Europe dibigatran (Volume) by Application

3 GERMANY DIBIGATRAN (VOLUME, VALUE AND SALES PRICE)

3.1 Germany dibigatran Sales and Value (2011-2021)
  3.1.1 Germany dibigatran Sales and Growth Rate (2011-2021)
  3.1.2 Germany dibigatran Revenue and Growth Rate (2011-2021)
  3.1.3 Germany dibigatran Sales Price Trend (2011-2021)
3.2 Germany dibigatran Sales and Market Share by Manufacturers
3.3 Germany dibigatran Sales and Market Share by Type
3.4 Germany dibigatran Sales and Market Share by Applications

4 UK DIBIGATRAN (VOLUME, VALUE AND SALES PRICE)

4.1 UK dibigatran Sales and Value (2011-2021)
  4.1.1 UK dibigatran Sales and Growth Rate (2011-2021)
  4.1.2 UK dibigatran Revenue and Growth Rate (2011-2021)
  4.1.3 UK dibigatran Sales Price Trend (2011-2021)
4.2 UK dibigatran Sales and Market Share by Manufacturers
4.3 UK dibigatran Sales and Market Share by Type
4.4 UK dibigatran Sales and Market Share by Applications

5 FRANCE DIBIGATRAN (VOLUME, VALUE AND SALES PRICE)

5.1 France dibigatran Sales and Value (2011-2021)
  5.1.1 France dibigatran Sales and Growth Rate (2011-2021)
  5.1.2 France dibigatran Revenue and Growth Rate (2011-2021)
  5.1.3 France dibigatran Sales Price Trend (2011-2021)
5.2 France dibigatran Sales and Market Share by Manufacturers
5.3 France dibigatran Sales and Market Share by Type
5.4 France dibigatran Sales and Market Share by Applications

6 ITALY DIBIGATRAN (VOLUME, VALUE AND SALES PRICE)

6.1 Italy dibigatran Sales and Value (2011-2021)
  6.1.1 Italy dibigatran Sales and Growth Rate (2011-2021)
  6.1.2 Italy dibigatran Revenue and Growth Rate (2011-2021)
  6.1.3 Italy dibigatran Sales Price Trend (2011-2021)
6.2 Italy dibigatran Sales and Market Share by Manufacturers
6.3 Italy dibigatran Sales and Market Share by Type
6.4 Italy dibigatran Sales and Market Share by Applications

7 RUSSIA DIBIGATRAN (VOLUME, VALUE AND SALES PRICE)

7.1 Russia dibigatran Sales and Value (2011-2021)
  7.1.1 Russia dibigatran Sales and Growth Rate (2011-2021)
  7.1.2 Russia dibigatran Revenue and Growth Rate (2011-2021)
  7.1.3 Russia dibigatran Sales Price Trend (2011-2021)
7.2 Russia dibigatran Sales and Market Share by Manufacturers
7.3 Russia dibigatran Sales and Market Share by Type
7.4 Russia dibigatran Sales and Market Share by Applications

8 SPAIN DIBIGATRAN (VOLUME, VALUE AND SALES PRICE)

8.1 Spain dibigatran Sales and Value (2011-2021)
  8.1.1 Spain dibigatran Sales and Growth Rate (2011-2021)
  8.1.2 Spain dibigatran Revenue and Growth Rate (2011-2021)
  8.1.3 Spain dibigatran Sales Price Trend (2011-2021)
8.2 Spain dibigatran Sales and Market Share by Manufacturers
8.3 Spain dibigatran Sales and Market Share by Type
8.4 Spain dibigatran Sales and Market Share by Applications

9 EUROPE DIBIGATRAN MANUFACTURERS ANALYSIS

9.1 Pfizer, Inc. (US)
  9.1.1 Company Basic Information,Manufacturing Base and Competitors
  9.1.2 dibigatran Product Type and Technology
    9.1.2.1 Type I
    9.1.2.2 Type II
  9.1.3 dibigatran Sales, Revenue, Price of Pfizer, Inc. (US) (2015 and 2016)
9.2 Bayer Healthcare AG (Germany)
  9.2.1 Company Basic Information,Manufacturing Base and Competitors
  9.2.2 dibigatran Product Type and Technology
    9.2.2.1 Type I
    9.2.2.2 Type II
  9.2.3 dibigatran Sales, Revenue, Price of Bayer Healthcare AG (Germany) (2015 and 2016)
9.3 GlaxoSmithKline Plc. (UK)
  9.3.1 Company Basic Information,Manufacturing Base and Competitors
  9.3.2 dibigatran Product Type and Technology
    9.3.2.1 Type I
    9.3.2.2 Type II
  9.3.3 dibigatran Sales, Revenue, Price of GlaxoSmithKline Plc. (UK) (2015 and 2016)
9.4 Boehringer Ingelheim (Germany)
  9.4.1 Company Basic Information,Manufacturing Base and Competitors
  9.4.2 dibigatran Product Type and Technology
    9.4.2.1 Type I
    9.4.2.2 Type II
  9.4.3 dibigatran Sales, Revenue, Price of Boehringer Ingelheim (Germany) (2015 and 2016)
9.5 Sanofi S.A. (France)
  9.5.1 Company Basic Information,Manufacturing Base and Competitors
  9.5.2 dibigatran Product Type and Technology
    9.5.2.1 Type I
    9.5.2.2 Type II
  9.5.3 dibigatran Sales, Revenue, Price of Sanofi S.A. (France) (2015 and 2016)
9.6 Abbott India Limited (India)
  9.6.1 Company Basic Information,Manufacturing Base and Competitors
  9.6.2 dibigatran Product Type and Technology
    9.6.2.1 Type I
    9.6.2.2 Type II
  9.6.3 dibigatran Sales, Revenue, Price of Abbott India Limited (India) (2015 and 2016)
9.7 Aspen Holdings (South Africa)
  9.7.1 Company Basic Information,Manufacturing Base and Competitors
  9.7.2 dibigatran Product Type and Technology
    9.7.2.1 Type I
    9.7.2.2 Type II
  9.7.3 dibigatran Sales, Revenue, Price of Aspen Holdings (South Africa) (2015 and 2016)
9.8 Bristol-Myers Squibb Company (US)
  9.8.1 Company Basic Information,Manufacturing Base and Competitors
  9.8.2 dibigatran Product Type and Technology
    9.8.2.1 Type I
    9.8.2.2 Type II
  9.8.3 dibigatran Sales, Revenue, Price of Bristol-Myers Squibb Company (US) (2015 and 2016)
9.9 Eisai Inc. (US)
  9.9.1 Company Basic Information,Manufacturing Base and Competitors
  9.9.2 dibigatran Product Type and Technology
    9.9.2.1 Type I
    9.9.2.2 Type II
  9.9.3 dibigatran Sales, Revenue, Price of Eisai Inc. (US) (2015 and 2016)
9.10 Mitsubishi Tanabe Pharma Corporation (Japan)
  9.10.1 Company Basic Information,Manufacturing Base and Competitors
  9.10.2 dibigatran Product Type and Technology
    9.10.2.1 Type I
    9.10.2.2 Type II
  9.10.3 dibigatran Sales, Revenue, Price of Mitsubishi Tanabe Pharma Corporation (Japan) (2015 and 2016)
9.11 Teva Pharmaceutical Industries Ltd. (Israel)
  9.11.1 Company Basic Information,Manufacturing Base and Competitors
  9.11.2 dibigatran Product Type and Technology
    9.11.2.1 Type I
    9.11.2.2 Type II
  9.11.3 dibigatran Sales, Revenue, Price of Teva Pharmaceutical Industries Ltd. (Israel) (2015 and 2016)

10 DIBIGATRAN TECHNOLOGY AND DEVELOPMENT TREND

10.1 dibigatran Technology Analysis
10.2 dibigatran Technology Development Trend

11 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of dibigatran
Table Classification of dibigatran
Figure Europe Sales Market Share of dibigatran by Types in 2015
Table Applications of dibigatran
Figure Europe Sales Market Share of dibigatran by Applications in 2015
Figure stroke Examples
Figure deep vein thrombosis Examples
Figure pulmonary embolism Examples
Figure systemic embolism Examples
Figure Germany dibigatran Revenue and Growth Rate (2011-2021)
Figure France dibigatran Revenue and Growth Rate (2011-2021)
Figure UK dibigatran Revenue and Growth Rate (2011-2021)
Figure Italy dibigatran Revenue and Growth Rate (2011-2021)
Figure Spain dibigatran Revenue and Growth Rate (2011-2021)
Figure Russia dibigatran Revenue and Growth Rate (2011-2021)
Table Europe dibigatran Sales, Revenue and Price (2011-2021)
Figure Europe dibigatran Sales and Growth Rate (2011-2021)
Figure Europe dibigatran Revenue and Growth Rate (2011-2021)
Table Europe dibigatran Sales of Key Manufacturers (2015 and 2016)
Table Europe dibigatran Sales Share by Manufacturers (2015 and 2016)
Figure 2015 dibigatran Sales Share by Manufacturers
Figure 2016 dibigatran Sales Share by Manufacturers
Table Europe dibigatran Revenue by Manufacturers (2015 and 2016)
Table Europe dibigatran Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Europe dibigatran Revenue Share by Manufacturers
Table 2016 Europe dibigatran Revenue Share by Manufacturers
Table Europe dibigatran Sales and Market Share by Type (2011-2021)
Table Europe dibigatran Sales Share by Type (2011-2021)
Figure Sales Market Share of dibigatran by Type (2011-2021)
Figure Europe dibigatran Sales Growth Rate by Type (2011-2021)
Table Europe dibigatran Revenue and Market Share by Type (2011-2021)
Table Europe dibigatran Revenue Share by Type (2011-2021)
Figure Revenue Market Share of dibigatran by Type (2011-2021)
Figure Europe dibigatran Revenue Growth Rate by Type (2011-2021)
Table Europe dibigatran Sales and Market Share by Regions (2011-2021)
Table Europe dibigatran Sales Share by Regions (2011-2021)
Figure Sales Market Share of dibigatran by Regions (2011-2021)
Figure Europe dibigatran Sales Growth Rate by Regions (2011-2021)
Table Europe dibigatran Revenue and Market Share by Regions (2011-2021)
Table Europe dibigatran Revenue Share by Regions (2011-2021)
Figure Revenue Market Share of dibigatran by Regions (2011-2021)
Figure Europe dibigatran Revenue Growth Rate by Regions (2011-2021)
Table Europe dibigatran Sales and Market Share by Application (2011-2021)
Table Europe dibigatran Sales Share by Application (2011-2021)
Figure Sales Market Share of dibigatran by Application (2011-2021)
Figure Europe dibigatran Sales Growth Rate by Application (2011-2021)
Figure Germany dibigatran Sales and Growth Rate (2011-2021)
Figure Germany dibigatran Revenue and Growth Rate (2011-2021)
Figure Germany dibigatran Sales Price Trend (2011-2021)
Table Germany dibigatran Sales by Manufacturers (2015 and 2016)
Table Germany dibigatran Market Share by Manufacturers (2015 and 2016)
Table Germany dibigatran Sales by Type (2015 and 2016)
Table Germany dibigatran Market Share by Type (2015 and 2016)
Table Germany dibigatran Sales by Applications (2015 and 2016)
Table Germany dibigatran Market Share by Applications (2015 and 2016)
Figure UK dibigatran Sales and Growth Rate (2011-2021)
Figure UK dibigatran Revenue and Growth Rate (2011-2021)
Figure UK dibigatran Sales Price Trend (2011-2021)
Table UK dibigatran Sales by Manufacturers (2015 and 2016)
Table UK dibigatran Market Share by Manufacturers (2015 and 2016)
Table UK dibigatran Sales by Type (2015 and 2016)
Table UK dibigatran Market Share by Type (2015 and 2016)
Table UK dibigatran Sales by Applications (2015 and 2016)
Table UK dibigatran Market Share by Applications (2015 and 2016)
Figure France dibigatran Sales and Growth Rate (2011-2021)
Figure France dibigatran Revenue and Growth Rate (2011-2021)
Figure France dibigatran Sales Price Trend (2011-2021)
Table France dibigatran Sales by Manufacturers (2015 and 2016)
Table France dibigatran Market Share by Manufacturers (2015 and 2016)
Table France dibigatran Sales by Type (2015 and 2016)
Table France dibigatran Market Share by Type (2015 and 2016)
Table France dibigatran Sales by Applications (2015 and 2016)
Table France dibigatran Market Share by Applications (2015 and 2016)
Figure Italy dibigatran Sales and Growth Rate (2011-2021)
Figure Italy dibigatran Revenue and Growth Rate (2011-2021)
Figure Italy dibigatran Sales Price Trend (2011-2021)
Table Italy dibigatran Sales by Manufacturers (2015 and 2016)
Table Italy dibigatran Market Share by Manufacturers (2015 and 2016)
Table Italy dibigatran Sales by Type (2015 and 2016)
Table Italy dibigatran Market Share by Type (2015 and 2016)
Table Italy dibigatran Sales by Applications (2015 and 2016)
Table Italy dibigatran Market Share by Applications (2015 and 2016)
Figure Russia dibigatran Sales and Growth Rate (2011-2021)
Figure Russia dibigatran Revenue and Growth Rate (2011-2021)
Figure Russia dibigatran Sales Price Trend (2011-2021)
Table Russia dibigatran Sales by Manufacturers (2015 and 2016)
Table Russia dibigatran Market Share by Manufacturers (2015 and 2016)
Table Russia dibigatran Sales by Type (2015 and 2016)
Table Russia dibigatran Market Share by Type (2015 and 2016)
Table Russia dibigatran Sales by Applications (2015 and 2016)
Table Russia dibigatran Market Share by Applications (2015 and 2016)
Figure Spain dibigatran Sales and Growth Rate (2011-2021)
Figure Spain dibigatran Revenue and Growth Rate (2011-2021)
Figure Spain dibigatran Sales Price Trend (2011-2021)
Table Spain dibigatran Sales by Manufacturers (2015 and 2016)
Table Spain dibigatran Market Share by Manufacturers (2015 and 2016)
Table Spain dibigatran Sales by Type (2015 and 2016)
Table Spain dibigatran Market Share by Type (2015 and 2016)
Table Spain dibigatran Sales by Applications (2015 and 2016)
Table Spain dibigatran Market Share by Applications (2015 and 2016)
Table Pfizer, Inc. (US) Basic Information List
Table dibigatran Sales, Revenue, Price of Pfizer, Inc. (US) (2015 and 2016)
Table Bayer Healthcare AG (Germany) Basic Information List
Table dibigatran Sales, Revenue, Price of Bayer Healthcare AG (Germany) (2015 and 2016)
Table GlaxoSmithKline Plc. (UK) Basic Information List
Table dibigatran Sales, Revenue, Price of GlaxoSmithKline Plc. (UK) (2015 and 2016)
Table Boehringer Ingelheim (Germany) Basic Information List
Table dibigatran Sales, Revenue, Price of Boehringer Ingelheim (Germany) (2015 and 2016)
Table Sanofi S.A. (France) Basic Information List
Table dibigatran Sales, Revenue, Price of Sanofi S.A. (France) (2015 and 2016)
Table Abbott India Limited (India) Basic Information List
Table dibigatran Sales, Revenue, Price of Abbott India Limited (India) (2015 and 2016)
Table Aspen Holdings (South Africa) Basic Information List
Table dibigatran Sales, Revenue, Price of Aspen Holdings (South Africa) (2015 and 2016)
Table Bristol-Myers Squibb Company (US) Basic Information List
Table dibigatran Sales, Revenue, Price of Bristol-Myers Squibb Company (US) (2015 and 2016)
Table Eisai Inc. (US) Basic Information List
Table dibigatran Sales, Revenue, Price of Eisai Inc. (US) (2015 and 2016)
Table Mitsubishi Tanabe Pharma Corporation (Japan) Basic Information List
Table dibigatran Sales, Revenue, Price of Mitsubishi Tanabe Pharma Corporation (Japan) (2015 and 2016)